MTOR and cancer: The target prediction and HTS2 assay results indicated that galloylpaeoniflorin might regulate several immune-related pathways (i.e., T cell receptor signaling pathway, Th17 cell differentiation, and B cell receptor signaling pathway), and cancer hallmarks pathways (i.e., MAPK signaling pathway, cell cycle, and mTOR signaling pathway) (Figure 5C).